In the current study, AFIFs were found to down-regulate the IL-13 level in vivo, indicating that AFIFs can inhibit the Th2 response in the allergic asthma mouse model, thus decreasing the IgE level in the serum. The gene discussed is IL13; the disease is allergic asthma.